Close
Nordic 9Nordic 9

SR One (investor - Corporate Investor)

United States srone.com
See something wrong or missing? Let us know
Offices:Cambridge

SR One is the corporate venture capital arm of GlaxoSmithKline.

Average round investment:74.43M USD
Average number per year:1.6
Distribution: 2025 (2)2024 (3)2022 (1)2021 (1)2020 (1)
Portfolio companies: United Kingdom Charm TherapeuticsUnited Kingdom Draig TherapeuticsDenmark Antag Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (6) Health services (8)
See the entire list

Showing 3 of 8 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

SR One mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to SR One

Name Criteria
United States Arch Venture Partners
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
United States Versant Ventures
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Denmark, Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Neo
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland Forestay Capital
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Italy H14
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Summit Partners
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Denmark, Switzerland
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United States Woodline Partners
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Software Services, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Netherlands BioGeneration Ventures
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Software Services, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United Kingdom HSBC
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
Investcorp
90%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Denmark, Switzerland
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Top